北陆药业: 关于北陆转债转股数额累计达到转股前公司已发行股份总额10%的公告

Core Points - The company announced that the cumulative number of shares converted from its convertible bonds, "Beilu Convertible Bonds," has reached 49,783,476 shares, accounting for 10.07% of the total shares issued before conversion and 9.19% of the latest total share capital [1][5] - As of the announcement date, there are still 1,503,327 "Beilu Convertible Bonds" unconverted, which represents 30.07% of the total issuance of 5,000,000 bonds [5] Convertible Bond Basic Information - The company issued a total of 500 million yuan worth of convertible bonds, which were approved by the China Securities Regulatory Commission and listed on December 11, 2020 [1] - The conversion period for the bonds started on June 11, 2021, and will last until December 6, 2026 [1] Conversion Price Adjustment - The initial conversion price was set at 11.41 yuan per share, which was later adjusted down to 8.86 yuan per share due to stock price conditions [2] - Subsequent adjustments were made to the conversion price, with the latest adjustment bringing it down to 7.02 yuan per share effective from May 19, 2025 [4][5]